These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 3802075)
1. 6-[Bis(2-chloroethyl)amino]-6-deoxygalactopyranose hydrochloride (C6-galactose mustard), a new alkylating agent with reduced bone marrow toxicity. Schein PS; Green D; Dean SW; McPherson E Cancer Res; 1987 Feb; 47(3):696-9. PubMed ID: 3802075 [TBL] [Abstract][Full Text] [Related]
2. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice. Cantrell JE; Green D; Schein PS Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728 [TBL] [Abstract][Full Text] [Related]
3. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice. Panasci LC; Green D; Schein PS J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033 [TBL] [Abstract][Full Text] [Related]
4. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas. Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398 [TBL] [Abstract][Full Text] [Related]
5. 6-bis-(2-chloroethyl)amino-6-deoxy-D-galactopyranose hydrochloride: synthesis, chemical characterization, murine P388 antitumor activity, and bone marrow toxicity. Schein PS; Green D; Hammer CF; McPherson E; Talebian A J Pharm Sci; 1989 Nov; 78(11):918-21. PubMed ID: 2621574 [TBL] [Abstract][Full Text] [Related]
6. Biological and biochemical properties of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity. Fox PA; Panasci LC; Schein PS Cancer Res; 1977 Mar; 37(3):783-7. PubMed ID: 138478 [TBL] [Abstract][Full Text] [Related]
7. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta. Borden EC; Sidky YA; Hatcher JF; Bryan GT Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000 [TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of WR-151327: an orally active chemotherapy protector. Green D; Bensely D; Schein P Cancer Res; 1994 Feb; 54(3):738-41. PubMed ID: 8306335 [TBL] [Abstract][Full Text] [Related]
9. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice. Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799 [TBL] [Abstract][Full Text] [Related]
10. Chlorozotocin, 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose, an antitumor agent with modified bone marrow toxicity. Anderson T; McMenamin MG; Schein PS Cancer Res; 1975 Mar; 35(3):761-5. PubMed ID: 123170 [TBL] [Abstract][Full Text] [Related]
11. Diethyldithiocarbamate inhibition of murine bone marrow toxicity caused by cis-diamminedichloroplatinum(II) or diammine-(1,1-cyclobutanedicarboxylato)platinum(II). Gringeri A; Keng PC; Borch RF Cancer Res; 1988 Oct; 48(20):5708-12. PubMed ID: 2844391 [TBL] [Abstract][Full Text] [Related]
12. Biologic effects of prolonged melphalan treatment of murine long-term bone marrow cultures and interleukin 3-dependent hematopoietic progenitor cell lines. Greenberger JS; Palaszynski EW; Pierce JH; Sakakeeny MA; Ruscetti SK; Ihle JN; Daugherty C J Natl Cancer Inst; 1985 Jan; 74(1):247-62. PubMed ID: 3918212 [TBL] [Abstract][Full Text] [Related]
13. Leukopenia and altered hematopoietic activity in mice exposed to the abused inhalant, isobutyl nitrite. Soderberg LS; Flick JT; Barnett JB Exp Hematol; 1996 Jun; 24(7):848-53. PubMed ID: 8647236 [TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of the 3'-chloroethylnitrosourea analog of thymidine and the prevention by co-administered thymidine of lethality but not of anticancer activity. Lin TS; Fischer PH; Marsh JC; Prusoff WH Cancer Res; 1982 May; 42(5):1624-9. PubMed ID: 7066884 [TBL] [Abstract][Full Text] [Related]
15. Sensitivity of human and murine hematopoietic precursor cells to 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose and 1,3-bis(2-chloroethyl)-1-nitrosourea. Schein PS; Bull JM; Doukas D; Hoth D Cancer Res; 1978 Feb; 38(2):257-60. PubMed ID: 620400 [TBL] [Abstract][Full Text] [Related]
16. Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo. Teicher BA; Holden SA; Eder JP; Brann TW; Jones SM; Frei E Cancer Res; 1989 Nov; 49(21):5994-8. PubMed ID: 2790813 [TBL] [Abstract][Full Text] [Related]
17. Ethanol mustard cytotoxicity in vitro toward murine leukemia and bone marrow progenitor cells. Naujokaitis SA; Fisher JM; Rabinovitz M Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):305-18. PubMed ID: 7302378 [TBL] [Abstract][Full Text] [Related]
18. Biological and biochemical properties of the 2-hydroxyl metabolites of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Heal JM; Fox PA; Doukas D; Schein PS Cancer Res; 1978 Apr; 38(4):1070-4. PubMed ID: 147730 [TBL] [Abstract][Full Text] [Related]
19. A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose. Nagourney RA; Fox P; Schein PS Cancer Res; 1978 Jan; 38(1):65-8. PubMed ID: 145314 [TBL] [Abstract][Full Text] [Related]